Obstetrical Impact of Anti-MUT (Anti-MNS35) Alloimmunization. [PDF]
Gavillet M +8 more
europepmc +1 more source
Haemolytic disease of the foetus and newborn due to anti-M: A systematic review. [PDF]
Wang L, Wang L, Huang Y, Cheng F, Tan B.
europepmc +1 more source
Compound heterozygous RHCE null genotype underlying D-- phenotype in a Chinese pregnant woman: molecular characterization and sequential transfusion strategy. [PDF]
Zhou W +8 more
europepmc +1 more source
Routine transfusion of Rh(D)-positive RBCs to Rh(D)-negative patients designated as do not resuscitate conserves Rh(D)-negative red blood cell inventory. [PDF]
Karp JK +5 more
europepmc +1 more source
Suppression of Compensatory Erythropoiesis in Hemolytic Disease of the Fetus and Newborn Due to Intrauterine Transfusions [PDF]
BACKGROUND: Infants with severe hemolytic disease of the fetus and newborn often require 1 or multiple intrauterine transfusions to treat fetal anemia. Intrauterine transfusions may have an inhibiting effect on fetal and neonatal erythropoiesis.OBJECTIVE:
Carolien Zwiers +2 more
exaly +2 more sources
Related searches:
Hemolytic Disease of the Fetus and Newborn
NeoReviews, 2013Hemolytic disease of the fetus and newborn (HDFN) is the result of immune-mediated destruction of fetal or newborn red blood cells when such cells contain antigens that are not present in the maternal blood. HDFN is now the preferred term that replaces the historic term erythroblastosis fetalis.
Mary Elizabeth Ross +3 more
+4 more sources
The management of hemolytic disease in the fetus and newborn
Seminars in Perinatology, 1997Rh hemolytic disease (HDN) is the prototype of maternal alloimmunization and fetal hemolytic disease. There are other antigens capable of causing alloimmunization and hemolytic disease such as c, Kell, and Fya. Rh immunization is usually caused by a prior Rh positive fetal maternal transplacental hemorrhage, which occurs in at least 75% of pregnancies.
openaire +2 more sources
Hemolytic Disease of the Fetus and Newborn Due to Multiple Maternal Antibodies
American Journal of Obstetrics and Gynecology, 2015The objective of the study was to determine whether women with combinations of red blood cell antibodies are more likely to develop significant hemolytic disease of the fetus and newborn than those with single antibodies.A retrospective exposure cohort study was conducted of pregnant women with red blood cell antibodies.
Haikady N Nagaraja, Karen Q Rossi
exaly +3 more sources

